Product image of Nasonex (Mometasone Furoate) supplied by GNH India

Nasonex

Active Ingredient:
Mometasone Furoate
Origin:
EU

Nasonex (Mometasone Furoate)

Mometasone furoate, the active ingredient in Nasonex, is a corticosteroid presented as a nasal spray for nasal use. The medication is formulated for once‑daily intranasal administration, providing localized anti‑inflammatory effects with minimal systemic absorption. It is indicated for the treatment of allergic rhinitis and nasal polyps in adults and children, as directed by a healthcare professional.

GNH India supplies Nasonex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets.

Manufacturer / TM Owner

N.V. Organon

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nasonex (mometasone furoate) is a nasal corticosteroid that reduces inflammation in the nasal passages.

  • Allergic rhinitis: alleviates nasal congestion, itching, and sneezing by decreasing mucosal inflammation.
  • Seasonal allergic rhinitis: provides symptom relief during pollen seasons through local anti‑inflammatory action.
  • Nasal polyps: shrinks polyp size and improves nasal airflow, helping to restore normal breathing.

How It Works

  • Mometasone furoate binds with high affinity to intracellular glucocorticoid receptors in nasal mucosal cells. The receptor complex translocates to the nucleus and modulates gene transcription, suppressing the production of pro‑inflammatory cytokines, chemokines, and adhesion molecules. This reduces inflammatory cell infiltration and edema in the nasal lining, delivering a potent local anti‑inflammatory effect with limited systemic exposure and resulting in rapid symptom control and improved nasal patency.

Side Effects

Nasonex may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Nasal irritation or burning
  • Headache
  • Epistaxis (nosebleed)
  • Throat irritation or cough

Serious or Rare Side Effects

  • Adrenal suppression leading to systemic corticosteroid effects
  • Glaucoma or cataract formation with prolonged use
  • Severe nasal septum perforation or fungal infection of the nasal mucosa

Precautions & Warnings

Before prescribing Nasonex, clinicians should evaluate the following precautions to ensure safe use.

  • Assess adrenal function: consider risk of systemic corticosteroid exposure, especially with long‑term use.
  • Monitor intraocular pressure: patients with glaucoma or a family history should have regular eye examinations.
  • Avoid use in untreated fungal infection: treat the infection before initiating therapy.
  • Use with caution in children: monitor growth velocity during prolonged treatment.
  • Store at room temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Nasonex can interact with other medicines; awareness of significant interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors: may increase systemic exposure to mometasone furoate.
  • Systemic corticosteroids: additive immunosuppressive effects can raise infection risk.
  • Live vaccines: reduced efficacy due to local immunosuppression.

Moderate Interactions (Monitor Closely)

  • Antifungal azoles (e.g., ketoconazole): may raise mometasone levels.
  • Ritonavir or other protease inhibitors: potential increase in corticosteroid exposure.
  • Diuretics: may affect electrolyte balance when systemic absorption occurs.

Frequently Asked Questions

Nasonex is prescribed for the management of allergic rhinitis, including seasonal and perennial forms, and for the treatment of nasal polyps. In both cases, the medication works locally in the nasal passages to reduce inflammation, relieve congestion, and improve breathing.

Mometasone furoate binds to glucocorticoid receptors in the cells lining the nasal mucosa. This binding alters gene expression, decreasing the production of inflammatory mediators such as cytokines and chemokines, which reduces swelling, mucus production, and irritation within the nose.

The specific dosing regimen for Nasonex is determined by the prescribing healthcare professional based on the patient’s age, condition severity, and response to therapy. Typically, the product is administered as one spray per nostril once daily, but the exact dose should follow the prescriber’s instructions.

Safety data for Nasonex in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using the medication.

To place an order, submit an enquiry on the Nasonex product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nasonex contains mometasone furoate, a high‑potency corticosteroid with strong local anti‑inflammatory activity and minimal systemic absorption. Compared with older agents such as fluticasone or budesonide, mometasone often requires fewer daily sprays to achieve similar symptom control, though individual response may vary.

Nasonex should be stored at room temperature, below 25 °C (77 °F). Keep the spray in its original packaging, protect it from moisture and direct heat, and ensure the cap is tightly closed when not in use.

The spray is used intranasally. After gently shaking the bottle, the user should prime the device if it is the first use, tilt the head slightly forward, insert the tip into one nostril, and press down to deliver a spray while breathing in gently. The process is repeated in the other nostril as directed.

Serious adverse effects, although rare, include adrenal suppression, which can lead to systemic corticosteroid symptoms, and ocular complications such as glaucoma or cataract formation with prolonged use. Severe local reactions like nasal septum perforation or opportunistic fungal infections may also occur and require immediate medical attention.

Nasonex should not be used by individuals with a known hypersensitivity to mometasone furoate or any component of the formulation. It is also contraindicated in patients with untreated fungal infections of the nose and should be used with caution in those with uncontrolled glaucoma, cataracts, or systemic infections.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT